[Retracted] Nomogram to Predict Overall and Cancer-Specific Survival in Patients with Synovial Sarcoma in the Extremities: A Population-Based Study

Table 2

Univariate and multivariate analysis of OS in the training cohort.

Characteristics	Univariate analysis HR (95% CI)	P	Multivariate analysis HR (95% CI)	P
Age	2 (1.11–3.62)	0.022	2.36 (1.13–4.92)	0.022
0–23
24–40
>40
Sex	0.42 (0.17–1.05)	0.063	0.48 (0.18–1.31)	0.152
Male
Female
Pathological type	1.17 (0.76–1.8)	0.477	NA	NA
Spindle cell
Epithelioid cell
Biphasic
Primary site	3.23 (0.75–13.86)	0.115	1.1 (0.2–5.96)	0.913
Upper
Lower
Tumor size (mm)	2.25 (1.3–3.89)	0.004	1.33 (0.54–3.25)	0.531
6–66
67–145
>145
Stage T	1.48 (0.98–2.21)	0.06	1.02 (0.56–1.89)	0.939
T1a
T1b
T2a
T2b
TX
Stage N	4.46 (1.92–10.33)	0.001	2.52 (0.88–7.24)	0.086
N0
N1
NX
Stage M	14.69 (6.04–35.72)	0.001	6.27 (2.13–18.5)	0.001
M0
M1
Radiation	1.98 (0.83–4.7)	0.123	1.27 (0.48–3.32)	0.629
Yes
No
Chemotherapy	0.22 (0.07–0.65)	0.006	0.53 (0.14–1.97)	0.344
Yes
No
Surgery	21.7 (5.76–81.79)	0.001	9.68 (2.05–45.69)	0.004
Yes
No